piracetam has been researched along with Acid beta-Glucosidase Deficiency in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Excerpt | Relevance | Reference |
---|---|---|
"We present the first reported case of a rapid clinical and electroencephalographic response to intravenous levetiracetam infusion of myoclonic status epilepticus in a patient with progressive myoclonus epilepsy due to Gaucher disease." | 7.78 | Gaucher disease: successful treatment of myoclonic status epilepticus with levetiracetam. ( Knight, EM; Lenz, T; Tuxhorn, I; Vaca, GF, 2012) |
"We present the first reported case of a rapid clinical and electroencephalographic response to intravenous levetiracetam infusion of myoclonic status epilepticus in a patient with progressive myoclonus epilepsy due to Gaucher disease." | 3.78 | Gaucher disease: successful treatment of myoclonic status epilepticus with levetiracetam. ( Knight, EM; Lenz, T; Tuxhorn, I; Vaca, GF, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vaca, GF | 1 |
Lenz, T | 1 |
Knight, EM | 1 |
Tuxhorn, I | 1 |
1 other study available for piracetam and Acid beta-Glucosidase Deficiency
Article | Year |
---|---|
Gaucher disease: successful treatment of myoclonic status epilepticus with levetiracetam.
Topics: Adolescent; Anticonvulsants; Electroencephalography; Epilepsies, Myoclonic; Gaucher Disease; Humans; | 2012 |